Third, genetic testing of the participants was not conducted, and the relationship between OLL2712 and genetic polymorphisms related to dementia; such as APOE, related to the risk of developing AD; IL-10, related to immunity; and plasminogen activator inhibitor-1, related to atherosclerosis; remains unknown. This evidence concerns the gene IL10 and Alzheimer disease.